Image-guided Therapy Systems Market Size & Share 2025 - 2034

Image-guided Therapy Systems Market Size

The global image-guided therapy systems market size was valued at USD 5.1 billion in 2024 and is projected to exhibit 7.3% CAGR from 2025-2034. The increasing incidence of chronic diseases, such as cancer, cardiovascular disease, and neurological disorders, fuels the demand for image-guided therapy systems.

For instance, according to the World Health Organization (WHO), chronic diseases cause 17.9 million deaths worldwide every year. The systems improve the accuracy of the treatment and minimize complications, resulting in improved patient outcomes. Additionally, the population growth with aging and lifestyle-related illnesses promotes the demand for sophisticated diagnostic and treatment interventions and therefore increases the use of image-guided technologies in health care centers.
 

Furthermore, technological innovations in medical imaging, such as real-time 3D medical imaging devices, AI-based guidance software, and robotic navigation, have enhanced the accuracy and safety of image-guided therapy. These technologies allow for better visualization of anatomical structures during surgery, resulting in improved surgical outcomes and reduced operation time. According to the National Institutes of Health (NIH), image-guided procedures exhibit a substantial decrease in procedure time compared with standard procedures, reflecting gains in surgery efficiency.
 

Moreover, the growing demand for minimally invasive procedures (MIS) is driven by patient demand for faster recovery, reduced pain, fewer complications, and shorter hospital stays. For instance, according to the National Institutes of Health (NIH), patients treated with open spinal surgery were 5.77 times greater than with MIS procedures. Image-guided treatment systems are an essential element in MIS surgery, providing real-time visualization and navigation support to complex procedures through small incisions.
 

Image-guided Therapy Systems Market Trends

• The application of AI and machine learning to image-guided therapy systems is transforming medical procedures. These technologies enhance image analysis, predictive diagnostics, and automatic guidance, boosting clinical decision and procedure accuracy.
   
• AI reduces variation in image interpretation and quality, lowering inconsistency and enhancing efficiency. Use of such systems is expected to grow as regulatory regimes evolve to accommodate AI-based medical devices.
   
• Increased application of hybrid operating rooms with cutting-edge imaging technology is transforming surgery. The operating rooms combine real-time diagnostic imaging and surgical instrumentation, allowing accurate interventions without patient repositioning.
   
• The need is greater in cardiology, neurosurgery, and oncology departments. Hybrid operating rooms are given priority by hospitals as a first-rate investment when renovating the surgical suite.
   
• The combination of robotic-assisted procedures with image-guidance systems offers greater control, accuracy, and visualization for intricate procedures. This combination is most common in orthopedics, urology, and gynecology. For example, Mazor X Stealth Edition offered by Medtronic integrates robotic guidance with real-time intraoperative 3D imaging through StealthStation navigation system.
   
• Robotic platforms with real-time imaging minimize surgeon fatigue, maximize procedural consistency, and minimize patient recovery times. Market growth is fueled by growing availability and affordability of robotic platforms.
   

Trump Administration Tariffs

• The medical imaging business depends upon the import of products such as sensors, semiconductors, and image modules from the tariff-impacted nations such as China. U.S. Tariffs are expected to result in disrupting and causing problems within logistics, which may lead manufacturers to scrutinize their relationship with suppliers, inventory practices, and supply chain resilience to prevent production disruption.
   
• Customs duties on image and navigation devices are expected to increase procurement prices, especially for companies with no alternative suppliers. As companies may not be able to pass added expenses to end-users, they may end up with lower profitability, postponed R&D investment, and risk-averse strategies.
   
• Profit margins might reduce, especially for low-budget hospitals or fixed-reimbursement rate markets.
   
• Vendors might seek new sourcing in non-tariff countries such as Southeast Asia, India, and Eastern Europe to address tariff-related issues. Although vendor migrations can involve qualification processes and can lead to temporary disruption, supply chain diversification is expected to become a requirement to ensure cost competitiveness and uninterrupted supply.
   
• Vendors are expected to step-up investment in local manufacturing plants, particularly in the U.S. and big markets, to offset tariff exposure. This can include reshoring assembly work, adding domestic production capacity, and partnerships with local OEMs. Local manufacturing is expected to offer further benefits beyond tariff avoidance, including faster delivery times, better regulatory compliance, and greater supply chain visibility.
   

Image-guided Therapy Systems Market Analysis

Based on product type, the market is segmented into X-ray/fluoroscopy, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and other product types. The X-ray/fluoroscopy segment dominated the market with the largest revenue share of 30.2% in 2024.
 

• X-ray/fluoroscopy-guided systems facilitate minimally invasive interventions in cardiology, orthopedics, and interventional radiology, this ensures there widespread application, ensuring the dominance of the segment.
   
• Further, advances such as real-time imaging functions across X-ray/fluoroscopy-guided systems to accurately guide catheters and instruments with improved procedural safety and results, rising their adoption.
   
• Moreover, growing patient demand for less surgical trauma and quicker recovery is also fueling the use of X-ray/fluoroscopy-guided systems in hospitals and outpatient environments.
   
• In addition, the rise in cardiovascular diseases, especially among elderly individuals, also boosts the demand for such treatments across angioplasties and stenting under fluoroscopy. For instance, according to the World Heart Federation, 20.5 million people died in 2021 due to a cardiovascular disease. The rising disease burden ensures the growing adoption of X-ray/fluoroscopy-guided systems globally.
   

Based on application, the image-guided therapy systems market is segmented into cardiac surgery, neurosurgery, orthopedic surgery, gastroenterology, urology, oncology, ENT surgery, and other applications. The oncology segment dominated the market with the largest revenue of USD 1.5 billion in 2024.
 

• The worldwide surge in cancer diagnoses is generating a demand for accurate, minimally invasive treatment modalities. As per the WHO, new cancer cases annually are expected to increase by 60% within the next two decades, with an estimated 29.5 million new cases by 2040.
   
• Image-guided therapy systems enable ablative and targeted radiation therapy with sparing of normal tissue. The transition to individualized oncology treatment requires real-time imaging for drug delivery, tumor removals, and biopsies, and hence these systems are a critical component of current cancer treatment protocols.
   
• Additionally, introduction of new technology in real-time imaging, most specifically the integration of MRI, CT, and PET with real-time fluoroscopy or ultrasound, has added further to tumor imaging intra-procedure. This allows for detection of small lesions, real-time modulation of treatment, and more precise measurement of response.
   
• These new capabilities are broadening the scope of image-guided system applications in radiofrequency ablation, brachytherapy, and stereotactic body radiotherapy (SBRT), resulting in improved patient outcomes and less recovery time.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the image-guided therapy systems market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and research and academic institutions. The hospitals segment dominated the market with a share of 62.2% in 2024.
 

• Hospitals also are implementing technologies that enhance surgery precision, reduce intraoperative complications, and provide better patient outcomes. The National Institutes of Health (NIH) states that 40-50% of surgical mistakes are made in operating rooms within hospitals. Image-guided therapy systems can provide real-time visualization and navigation during advanced surgical procedures.
   
• The integration of image-guided therapy systems into operating rooms across hospitals is increasingly the norm in high-acuity environments in an effort to reduce surgical errors and post-surgical complications. The innovation aligns with WHO's Global Patient Safety Action Plan 2021-2030. The key objective of this plan is to emphasize the gains of safer surgery practice.
   
• Further, hybrid operating rooms are being developed by hospitals that combine traditional surgical suites with advanced imaging capability. Image-guided therapy systems, including intraoperative CT, MRI, and fluoroscopy units, enable real-time surgical decision-making.
   
• These investments are within the broader trends of adopting multifunctional, technology-enabled facilities that include cardiology, neurosurgery, and oncology procedures, with consistent demand for these systems. Therefore, the aforementioned factors are expected to significantly boost segment growth over the forecast period.

North America: The U.S. image-guided therapy systems market is projected to grow significantly from USD 2.1 billion in 2024 to USD 4.1 billion by 2034.
 

• The U.S. health care system is shifting toward value-based care in which the providers and hospitals are reimbursed according to patient outcomes instead of quantity of services.
   
• Image-guided therapy systems improve surgical accuracy, minimize complications, and decrease recovery time. The adoption of these systems across U.S. is enabling the providers to achieve performance goals for Medicare and private payer programs, making them a strategic investment for hospitals that prioritize improving care quality and keeping costs in line.
   
• Further, the U.S. has an increasing number of elderly people suffering from rising rates of chronic diseases like cancer, cardiovascular diseases, and musculoskeletal diseases. The U.S. Census Bureau projects that the population aged 65 and older will increase to 77 million by 2034. These patients most often remains under Medicare or private insurance and are among the beneficiaries of minimally invasive treatments by image-guided systems. As a result, this drives the adoption of image guided therapy systems in the U.S.
   

Europe: The image-guided therapy systems market in UK is expected to experience significant and promising growth from 2025 to 2034.
 

• The UK National Health Service (NHS) is making investments in surgery modernization and digital healthcare technology through initiatives such as the NHS Long Term Plan. As, image-guided therapy systems enable faster, safer, and more efficient surgery, they have become consistent with NHS objectives to reduce waiting times, improve patient outcomes, and enhance operating room efficiency. This NHS policy convergence is leading to adoption throughout NHS Trusts and specialist surgical units.
   
• In addition, the aging population in the UK are increasingly suffering from long-term illness like cancer, cardiovascular disease, and deteriorating joints. The House of Commons Library in 2022 stated that nearly 12.7 million people over the age of 65 constitute 19% of all individuals residing in the UK. Such older patients require treatment with fewer operative hazards and quicker recovery time, which image-guided minimally invasive treatment can provide.
   
• The emphasis of the NHS on day-cases and shorter in-hospital stays is generating demand for higher-level imaging modalities, particularly in regional centers and community hospitals. Demographics of elderly age group, coupled with the documented benefits of minimally invasive therapy, are accelerating the adoption of image-guided therapy systems across the UK.
   

Asia Pacific: Japan image-guided therapy systems market is anticipated to witness lucrative growth between 2025 – 2034.
 

• Japan's aging population is creating a huge demand for minimally invasive procedures. The World Health Organization (WHO) states that Japan's life expectancy in 2023 was 84.95 years, the highest in the world. The Japanese Statistics Bureau states that the percentage of elderly citizens is expected to be 35.3% by 2040.
   
• Image-guided therapy systems make precise treatment and reduce surgery-related risk and healing time, and hence present vital instruments in treating cancer, cardiovascular disease, and orthopedic disorders prevalent among the elderly population. This population trend corresponds to a sustained upsurge in demand for advanced medical imaging technology.
   
• Japan's Ministry of Health, Labour and Welfare (MHLW) legislates simplified approval and payment mechanisms for advanced medical technologies. These regulatory configurations enable the hospital to address changes more quickly in order to install image-guided therapy systems.
   

Middle East and Africa: The Saudi Arabia image-guided therapy systems market is expected to experience significant and promising growth from 2025 to 2034.
 

• Saudi Arabia's Vision 2030 program is transforming the healthcare industry by emphasizing digital health and innovative medical technologies. Image-guided therapy systems enhance the government's initiative to enhance the quality of care, efficiency, and patient outcomes.
   
• The modernization of the hospital and adoption of international healthcare standards create a greater demand for image-guided procedures in real time for public and private healthcare institutions in surgical, oncologic, and cardiac interventions.
   
• The rising incidence of chronic diseases in Saudi Arabia, such as cancer, obesity, diabetes, and cardiovascular diseases, necessitates repeated imaging, interventions, and minimally invasive procedures.
   
• According to the International Diabetes Federation (IDF), diabetes prevalence in 2021 was around 17.7%. Expanding the patient base and clinical demand fuel market expansion in specialty care facilities and tertiary care facilities, making advanced imaging technology crucial to meet the escalating healthcare demands in the region.
   

Image-guided Therapy Systems Market Share

The market has a dynamic mix of international and domestic players providing innovative solutions to meet the growing demand for advanced imaging systems for the growing patient population. Companies such as Siemens Healthineers, GE HealthCare, Medtronic, Koninklijke Philips, and Stryker are some of the dominant competitors in the market accounting for a combined market share of approximately 65%.
 

Competition in this area arises from continuous technological developments and the ability to offer customized solutions for various image guided treatment applications. In developing nations, due to the priority given to cost, multinational companies are squeezed to offer image-guided therapy systems that are both affordable and of quality. Domestic manufacturers take advantage of this demand by providing cost effective alternatives, which make multinationals alter their price strategy while maintaining the safety, ruggedness, and regulatory acceptability of the products.
 

Image-guided Therapy Systems Market Companies

Some of the eminent market participants operating in the image-guided therapy systems industry include:

• Accuray
• Analogic
• Brainlab
• Canon Medical Systems
• Fujifilm Holdings
• GE HealthCare
• Intuitive Surgical
• Karl Storz
• Koninklijke Philips
• Medtronic
• Olympus
• Siemens Healthineers
• Smith & Nephew
• Stryker
• Zimmer Biomet
   
• Siemens Healthineers offers multimodal imaging and hybrid OR platforms, including its ARTIS pheno robotic angiography system and MRI-guided therapy systems. The company has integrated imaging platforms (fluoroscopy, MRI, CT) and surgery navigation to allow accurate execution of complex procedures like cardiac interventions and tumor ablations.
   
• GE HealthCare's O-arm Surgical Imaging System, a mobile intraoperative CT scanner, benefits spine, orthopedic, and neurological procedures with real-time 3D imaging. The company's LOGIQ and Vivid series ultrasound-guided therapy products enable minimally invasive cardiology and oncology procedures. The Edison Platform utilizes AI to streamline imaging workflows and reduce radiation exposure.
   
• Medtronic's StealthStation platform is the gold standard for neurosurgery, spine, and ENT procedures. Medtronic's offerings include the Mazor X robot-guided spine implant system and the Hugo RAS robotic surgery system. Its Touch Surgery platform employs AI analysis to deliver procedure insights to surgeons, improving safety and operational efficacy.
   

Image-guided Therapy Systems Industry News:

• In February 2024, Koninklijke Philips, a global leader in health technology, announced the launch of the Philips Image Guided Therapy Mobile C-arm System 9000 - Zenition 90 Motorized, designed to support surgeons in delivering high-quality care to more patients. The launch expanded the company’s image-guided therapy portfolio and enhanced its competitive position in the market.
   
• In October 2023, GE HealthCare announced that its Allia IGS Pulse system received 510(k) clearance from the U.S. FDA. The system featured a newly designed imaging chain that delivered high-quality imaging at optimized radiation doses, supporting complex cardiology interventions across all patient sizes. This approval strengthens the company’s interventional portfolio and helps to reinforce its position in the advanced image-guided therapy systems market.
   
• In July 2023, Stryker, a leading global medical technology company, commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance solution for instrument positioning and anatomical identification during cranial procedures. The launch enhanced Stryker’s neurosurgical navigation portfolio and reinforced its position in the image-guided cranial surgery market.
   
• In December 2020, Koninklijke Philips and InSightec, a global healthcare company specializing in the therapeutic use of acoustic energy, announced a collaboration to expand access to MR-guided focused ultrasound for incisionless neurosurgery. The partnership strengthened Koninklijke Philips’ neurosurgery portfolio and supported its strategic focus on advancing minimally invasive, image-guided therapeutic solutions.
   

The image-guided therapy systems market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Product Type

• X-ray/fluoroscopy
• Ultrasound
• Computed tomography
• Magnetic resonance imaging
• Positron emission tomography
• Other product types

By Application

• Cardiac surgery
• Neurosurgery
• Orthopedic surgery
• Gastroenterology
• Urology
• Oncology
• ENT surgery
• Other applications

By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics
• Research and academic institutions

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific 
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE